Drug-delivery specialist Zogenix, which recently re-filed for a $90 million initial public offering (IPO), reveals in its latest prospectus that its sales so far this year reached $14.6 million, most...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)